BIONET Therapeutics Statistics
Total Valuation
TPEX:7808 has a market cap or net worth of TWD 2.07 billion. The enterprise value is 1.08 billion.
Important Dates
The next estimated earnings date is Friday, March 19, 2027.
| Earnings Date | Mar 19, 2027 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:7808 has 70.00 million shares outstanding. The number of shares has increased by 1.91% in one year.
| Current Share Class | 70.00M |
| Shares Outstanding | 70.00M |
| Shares Change (YoY) | +1.91% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 5.89% |
| Owned by Institutions (%) | 1.91% |
| Float | 35.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.78 |
| PB Ratio | 1.75 |
| P/TBV Ratio | 1.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.08 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.98, with a Debt / Equity ratio of 0.02.
| Current Ratio | 15.98 |
| Quick Ratio | 15.05 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -166.41 |
Financial Efficiency
Return on equity (ROE) is -5.77% and return on invested capital (ROIC) is -4.45%.
| Return on Equity (ROE) | -5.77% |
| Return on Assets (ROA) | -5.42% |
| Return on Invested Capital (ROIC) | -4.45% |
| Return on Capital Employed (ROCE) | -7.21% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 105 |
| Asset Turnover | 0.17 |
| Inventory Turnover | 2.14 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.14% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -47.14% |
| 50-Day Moving Average | 35.85 |
| 200-Day Moving Average | 39.04 |
| Relative Strength Index (RSI) | 27.22 |
| Average Volume (20 Days) | 14,972 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:7808 had revenue of TWD 211.96 million and -69.24 million in losses. Loss per share was -0.99.
| Revenue | 211.96M |
| Gross Profit | 120.01M |
| Operating Income | -86.78M |
| Pretax Income | -69.24M |
| Net Income | -69.24M |
| EBITDA | -63.94M |
| EBIT | -86.78M |
| Loss Per Share | -0.99 |
Full Income Statement Balance Sheet
The company has 1.02 billion in cash and 22.52 million in debt, with a net cash position of 994.36 million or 14.21 per share.
| Cash & Cash Equivalents | 1.02B |
| Total Debt | 22.52M |
| Net Cash | 994.36M |
| Net Cash Per Share | 14.21 |
| Equity (Book Value) | 1.19B |
| Book Value Per Share | 17.33 |
| Working Capital | 1.05B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -25.49 million and capital expenditures -23.67 million, giving a free cash flow of -49.16 million.
| Operating Cash Flow | -25.49M |
| Capital Expenditures | -23.67M |
| Depreciation & Amortization | 22.85M |
| Net Borrowing | -3.32M |
| Free Cash Flow | -49.16M |
| FCF Per Share | -0.70 |
Full Cash Flow Statement Margins
Gross margin is 56.62%, with operating and profit margins of -40.94% and -32.67%.
| Gross Margin | 56.62% |
| Operating Margin | -40.94% |
| Pretax Margin | -32.67% |
| Profit Margin | -32.67% |
| EBITDA Margin | -30.16% |
| EBIT Margin | -40.94% |
| FCF Margin | n/a |
Dividends & Yields
TPEX:7808 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.91% |
| Shareholder Yield | -1.91% |
| Earnings Yield | -3.34% |
| FCF Yield | -2.37% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |